Nearly three quarters of U.S. adults are overweight or obese, according to a sweeping new study. The findings have ...

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...

There are three types of diabetes: type 1 (usually childhood onset), type 2 (usually adult onset), and gestational (during ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

Ozempic and other similar weight-loss drugs (collectively known as GLP-1 agonists) have revolutionized the treatment of ...

"We have seen an alarming rise in diabetes over the past three decades, which reflects the increase in obesity, compounded by the impacts of the marketing of unhealthy food, a lack of physical ...

A phase 3 trial found that Eli Lilly's tirzepatide significantly reduced the risk of progression to Type 2 diabetes in prediabetic adults over a three-year period. Nearly 99% of individuals treated ...

A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...

Young adults with type 2 diabetes and lower incomes face significantly higher mortality risks, highlighting socioeconomic ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...